Up-front Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia Patients Aged 65-75

NCT03902665 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

19

Enrollment

OTHER

Sponsor class

Conditions

Acute Myeloid Leukemia, Adult

Interventions

DRUG: Up-front allogeneic hematopoietic stem cell transplantation (HSCT)

Sponsor

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Collaborators

[object Object]